🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareHair loss on GLP-1 agonists: telogen effluvium vs nutritional deficiency — 6 month update Page 5

Hair loss on GLP-1 agonists: telogen effluvium vs nutritional deficiency — 6 month update

TrialTracker_MD Tue, Nov 11, 2025 at 4:36 PM 23 replies 1,449 viewsPage 5 of 5
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Nov 28, 2025 at 3:36 AM#21

One thing that is still open after Dr.LeslieOBGYN’s answer:

How long did you give it before you decided it was working?

Last edited: Nov 28, 2025 at 9:36 AM
29 4Dr.EndoEP, GraceAZ_72, carl_compliance and 26 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Dec 4, 2025 at 5:21 AM#22
SallyK_inj said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

28 3anna.melb_AU, mark_tokyo, hans_munich and 25 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Dec 10, 2025 at 7:09 AM#23
SallyK_inj said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

27 2Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Dec 16, 2025 at 9:01 AM#24
SallyK_inj said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

That reframing is the part I needed.

Last edited: Dec 16, 2025 at 1:01 PM
26 1Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 23 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Dec 22, 2025 at 10:56 AM#25

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

25 0dan_philly, MeganSA_TX, LarryQC_SD and 22 others
Reply Quote Save Share Report
1345

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register